PDE9A anticorps (N-Term)
Aperçu rapide pour PDE9A anticorps (N-Term) (ABIN630634)
Antigène
Voir toutes PDE9A AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- PDE9 A antibody was raised against the N terminal of PDE9
-
Purification
- Affinity purified
-
Immunogène
- PDE9 A antibody was raised using the N terminal of PDE9 corresponding to a region with amino acids SDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPET
-
-
-
-
Indications d'application
-
WB: 1 µg/mL, IHC: 4-8 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
PDE9A Blocking Peptide, (ABIN5615280), is also available for use as a blocking control in assays to test for specificity of this PDE9A antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of PDE0 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- PDE9A (phosphodiesterase 9A (PDE9A))
-
Autre désignation
- PDE9A
-
Sujet
- PDE9A catalyzes the hydrolysis of cAMP and cGMP to their corresponding monophosphates. The protein plays a role in signal transduction by regulating the intracellular concentration of these cyclic nucleotides.
-
Poids moléculaire
- 61 kDa (MW of target protein)
Antigène
-